Dietary supplementation of n-3 LCPUFAs prevents salmonellosis in a murine model.
Salmonellosis is a world-wide epidemic, and n-3 polyunsaturated fatty acids (PUFAs) possesses various health benefits. This study aimed to investigate the preventive effects of n-3 PUFAs against Salmonella infection. In vivo studies showed that n-3, but not n-6 PUFAs, increased the survival rate of infected mice. Further studies demonstrated that n-3 PUFAs significantly increased the fecal contents of short-chain fatty acids (SCFAs). The liver cytokine expression and serum cytokine production were both modulated by n-3 PUFAs into an anti-inflammatory profile against infection. Moreover, the changes in gut microbiota by n-3 PUFAs favored host against pathogens, and closely related to the modified SCFAs production and immune responses. In conclusion, n-3 PUFAs prevented Salmonella infection through multiple mechanisms, especially by interaction with gut microbiota and host immunology. Our results suggested great perspectives for n-3 PUFAs and their related products to control the prevalence of Salmonella, a most predominant food-borne pathogen.